Compass Therapeutics Inc (CMPX) Implied Volatility Current

Tracking CMPX implied volatility helps you identify when options premiums on Compass Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Compass Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when CMPX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Compass Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CMPX, tracking metrics like CMPX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CMPX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1.

The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CMPX implied volatility sits today versus where it has been. Our scanner ranks Compass Therapeutics Inc implied volatility against its historical range, surfaces extremes in CMPX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Compass Therapeutics Inc IV is rich or cheap — measure it, then act on it.